Cargando…
Automated PD-L1 Scoring for Non-Small Cell Lung Carcinoma Using Open-Source Software
PD-L1 expression in non-small cell lung cancer (NSCLC) is predictive of response to immunotherapy, but scoring of PD-L1 immunohistochemistry shows considerable interobserver variability. Automated methods may allow more consistent and expedient PD-L1 scoring. We aimed to assess the technical concord...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262183/ https://www.ncbi.nlm.nih.gov/pubmed/34257575 http://dx.doi.org/10.3389/pore.2021.609717 |
_version_ | 1783719140019666944 |
---|---|
author | Naso, Julia R. Povshedna, Tetiana Wang, Gang Banyi, Norbert MacAulay, Calum Ionescu, Diana N. Zhou, Chen |
author_facet | Naso, Julia R. Povshedna, Tetiana Wang, Gang Banyi, Norbert MacAulay, Calum Ionescu, Diana N. Zhou, Chen |
author_sort | Naso, Julia R. |
collection | PubMed |
description | PD-L1 expression in non-small cell lung cancer (NSCLC) is predictive of response to immunotherapy, but scoring of PD-L1 immunohistochemistry shows considerable interobserver variability. Automated methods may allow more consistent and expedient PD-L1 scoring. We aimed to assess the technical concordance of PD-L1 scores produced using free open source QuPath software with the manual scores of three pathologists. A classifier for PD-L1 scoring was trained using 30 NSCLC image patches. A separate test set of 207 image patches from 69 NSCLC resection cases was used for comparison of automated and manual scores. Automated and average manual scores showed excellent correlation (concordance correlation coeffecient = 0.925), though automated scoring resulted in significantly more 1–49% scores than manual scoring (p = 0.012). At both 1% and 50% thresholds, automated scores showed a level of concordance with our ‘gold standard’ (the average of three pathologists’ manual scores) similar to that of individual pathologists. Automated scoring showed high sensitivity (95%) but lower specificity (84%) at a 1% threshold, and excellent specificity (100%) but lower sensitivity (71%) at a 50% threshold. We conclude that our automated PD-L1 scoring system for NSCLC has an accuracy similar to that of individual pathologists. The detailed protocol we provide for free open source scoring software and our discussion of the limitations of this technology may facilitate more effective integration of automated scoring into clinical workflows. |
format | Online Article Text |
id | pubmed-8262183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82621832021-07-12 Automated PD-L1 Scoring for Non-Small Cell Lung Carcinoma Using Open-Source Software Naso, Julia R. Povshedna, Tetiana Wang, Gang Banyi, Norbert MacAulay, Calum Ionescu, Diana N. Zhou, Chen Pathol Oncol Res Society Journal Archive PD-L1 expression in non-small cell lung cancer (NSCLC) is predictive of response to immunotherapy, but scoring of PD-L1 immunohistochemistry shows considerable interobserver variability. Automated methods may allow more consistent and expedient PD-L1 scoring. We aimed to assess the technical concordance of PD-L1 scores produced using free open source QuPath software with the manual scores of three pathologists. A classifier for PD-L1 scoring was trained using 30 NSCLC image patches. A separate test set of 207 image patches from 69 NSCLC resection cases was used for comparison of automated and manual scores. Automated and average manual scores showed excellent correlation (concordance correlation coeffecient = 0.925), though automated scoring resulted in significantly more 1–49% scores than manual scoring (p = 0.012). At both 1% and 50% thresholds, automated scores showed a level of concordance with our ‘gold standard’ (the average of three pathologists’ manual scores) similar to that of individual pathologists. Automated scoring showed high sensitivity (95%) but lower specificity (84%) at a 1% threshold, and excellent specificity (100%) but lower sensitivity (71%) at a 50% threshold. We conclude that our automated PD-L1 scoring system for NSCLC has an accuracy similar to that of individual pathologists. The detailed protocol we provide for free open source scoring software and our discussion of the limitations of this technology may facilitate more effective integration of automated scoring into clinical workflows. Frontiers Media S.A. 2021-03-26 /pmc/articles/PMC8262183/ /pubmed/34257575 http://dx.doi.org/10.3389/pore.2021.609717 Text en Copyright © 2021 Naso, Povshedna, Wang, Banyi, MacAulay, Ionescu and Zhou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Society Journal Archive Naso, Julia R. Povshedna, Tetiana Wang, Gang Banyi, Norbert MacAulay, Calum Ionescu, Diana N. Zhou, Chen Automated PD-L1 Scoring for Non-Small Cell Lung Carcinoma Using Open-Source Software |
title | Automated PD-L1 Scoring for Non-Small Cell Lung Carcinoma Using Open-Source Software |
title_full | Automated PD-L1 Scoring for Non-Small Cell Lung Carcinoma Using Open-Source Software |
title_fullStr | Automated PD-L1 Scoring for Non-Small Cell Lung Carcinoma Using Open-Source Software |
title_full_unstemmed | Automated PD-L1 Scoring for Non-Small Cell Lung Carcinoma Using Open-Source Software |
title_short | Automated PD-L1 Scoring for Non-Small Cell Lung Carcinoma Using Open-Source Software |
title_sort | automated pd-l1 scoring for non-small cell lung carcinoma using open-source software |
topic | Society Journal Archive |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262183/ https://www.ncbi.nlm.nih.gov/pubmed/34257575 http://dx.doi.org/10.3389/pore.2021.609717 |
work_keys_str_mv | AT nasojuliar automatedpdl1scoringfornonsmallcelllungcarcinomausingopensourcesoftware AT povshednatetiana automatedpdl1scoringfornonsmallcelllungcarcinomausingopensourcesoftware AT wanggang automatedpdl1scoringfornonsmallcelllungcarcinomausingopensourcesoftware AT banyinorbert automatedpdl1scoringfornonsmallcelllungcarcinomausingopensourcesoftware AT macaulaycalum automatedpdl1scoringfornonsmallcelllungcarcinomausingopensourcesoftware AT ionescudianan automatedpdl1scoringfornonsmallcelllungcarcinomausingopensourcesoftware AT zhouchen automatedpdl1scoringfornonsmallcelllungcarcinomausingopensourcesoftware |